Morgan Stanley’s Maravai LifeSciences MRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.93M | Buy |
2,877,040
+342,069
| +13% | +$824K | ﹤0.01% | 3787 |
|
|
2025
Q1 | $5.6M | Buy |
2,534,971
+301,902
| +14% | +$667K | ﹤0.01% | 3838 |
|
|
2024
Q4 | $12.2M | Sell |
2,233,069
-466,670
| -17% | -$2.54M | ﹤0.01% | 3244 |
|
|
2024
Q3 | $22.4M | Buy |
2,699,739
+979,391
| +57% | +$8.14M | ﹤0.01% | 2687 |
|
|
2024
Q2 | $12.3M | Sell |
1,720,348
-884,418
| -34% | -$6.33M | ﹤0.01% | 3150 |
|
|
2024
Q1 | $22.6M | Sell |
2,604,766
-3,133,530
| -55% | -$27.2M | ﹤0.01% | 2559 |
|
|
2023
Q4 | $37.6M | Buy |
5,738,296
+4,312,057
| +302% | +$28.2M | ﹤0.01% | 2748 |
|
|
2023
Q3 | $14.3M | Sell |
1,426,239
-404,475
| -22% | -$4.04M | ﹤0.01% | 2793 |
|
|
2023
Q2 | $22.8M | Sell |
1,830,714
-702,218
| -28% | -$8.73M | ﹤0.01% | 2350 |
|
|
2023
Q1 | $35.5M | Buy |
2,532,932
+706,814
| +39% | +$9.9M | ﹤0.01% | 1863 |
|
|
2022
Q4 | $26.1M | Buy |
1,826,118
+522,612
| +40% | +$7.48M | ﹤0.01% | 2068 |
|
|
2022
Q3 | $33.3M | Sell |
1,303,506
-1,531,611
| -54% | -$39.1M | ﹤0.01% | 1670 |
|
|
2022
Q2 | $80.5M | Sell |
2,835,117
-7,904
| -0.3% | -$225K | 0.01% | 1058 |
|
|
2022
Q1 | $100M | Buy |
2,843,021
+322,568
| +13% | +$11.4M | 0.01% | 865 |
|
|
2021
Q4 | $106M | Sell |
2,520,453
-27,598
| -1% | -$1.16M | 0.01% | 859 |
|
|
2021
Q3 | $125M | Buy |
2,548,051
+636,173
| +33% | +$31.2M | 0.02% | 714 |
|
|
2021
Q2 | $79.8M | Buy |
1,911,878
+504,083
| +36% | +$21M | 0.01% | 991 |
|
|
2021
Q1 | $50.2M | Buy |
1,407,795
+1,381,269
| +5,207% | +$49.2M | 0.01% | 1171 |
|
|
2020
Q4 | $744K | Buy |
+26,526
| New | +$744K | ﹤0.01% | 4833 |
|